Claims for Patent: 6,201,105

✉ Email this page to a colleague

Summary for Patent: 6,201,105

Title:	Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)
Abstract:	Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.
Inventor(s):	Smith; Craig A. (Seattle, WA), Goodwin; Raymond G. (Seattle, WA), Beckmann; M. Patricia (Poulsbo, WA)
Assignee:
Application Number:	09/233,461
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,201,105
Patent Claims:	1. A recombinant protein comprising amino acids 1-163 of FIGS. 2A-2B, and wherein said recombinant protein binds TNF. 2. The recombinant protein of claim 1, wherein said protein comprises amino acids 1-185 of FIGS. 2A-2B. 3. The recombinant protein of claim 1, wherein said protein comprises amino acids 1-235 of FIGS. 2A-2C. 4. The recombinant protein of claim 1, wherein said extracellular region does not have native-pattern glycosylation.

Details for Patent 6,201,105

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Immunex Corporation	ENBREL	etanercept	For Injection	103795	November 02, 1998	⤷ Sign Up	2009-09-05
Immunex Corporation	ENBREL	etanercept	For Injection	103795	May 27, 1999	⤷ Sign Up	2009-09-05
Immunex Corporation	ENBREL	etanercept	Injection	103795	September 27, 2004	⤷ Sign Up	2009-09-05
Immunex Corporation	ENBREL	etanercept	Injection	103795	February 01, 2007	⤷ Sign Up	2009-09-05
Immunex Corporation	ENBREL MINI	etanercept	Injection	103795	September 14, 2017	⤷ Sign Up	2009-09-05
Immunex Corporation	ENBREL	etanercept	Injection	103795		⤷ Sign Up	2009-09-05
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 6,201,105

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
South Africa	907072	⤷ Sign Up
World Intellectual Property Organization (WIPO)	9406476	⤷ Sign Up
World Intellectual Property Organization (WIPO)	9319777	⤷ Sign Up
World Intellectual Property Organization (WIPO)	9103553	⤷ Sign Up
United States of America	RE36755	⤷ Sign Up
United States of America	7459528	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.